LONG-TERM NON-INTERVENTIONAL SAFETY STUDY OF EMICIZUMAB TREATMENT IN PATIENTS WITH MODERATE HAEMOPHILIA A AND SEVERE BLEEDING PHENOTYPE (STUDY BO44691, PASS)

13/06/2024
26/05/2026
EU PAS number:
EUPAS1000000174
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Prot BO44691 emicizumab v2, Published Output-1_Redacted.pdf

English (1.97 MB - PDF) View document
Updated protocol

Prot BO44691 emicizumab v3, Published Output_Redacted.pdf

First published: 07/05/2025
English (1.8 MB - PDF) View document
Study results
Study report
Other information